Validation of the International Prognostic Index and Subsequent Revisions for Diffuse Large B-Cell Lymphoma in Patients From the Middle East and North Africa Region

Diffuse large B-cell lymphoma (DLBCL) is a heterogenous disease with a variable prognosis. The International Prognostic Index (IPI), revised-IPI (R-IPI), and National Comprehensive Cancer Network-IPI (NCCN-IPI) have been developed and validated to predict prognosis in DLBCL. However, patients from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamer, Faisal, Alamir, Ahmad, Alqahtani, Abdulrahman, Alkabli, Abdulrahman M, Alshabib, Homod, Damlaj, Moussab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478920/
https://www.ncbi.nlm.nih.gov/pubmed/32923221
http://dx.doi.org/10.7759/cureus.9620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478920/
https://www.ncbi.nlm.nih.gov/pubmed/32923221
http://dx.doi.org/10.7759/cureus.9620

Ejemplares similares